Action Required: Password Reset on Next Login
As part of our recent security and system improvements, a password reset will be required the next time you log in. This applies to username/password users only; SSO users are not affected.
To reset your password, please visit the Reset Password page.
We appreciate your patience during this transition and are available to assist with any questions. For support, please call us at +1 650-552-4224 or email us at support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Forge Therapeutics Inc.
Headquarters: San Diego, CA, United States of America
Website: http://www.forgetherapeutics...
Year Founded: 2015
Status: Private
BioCentury | Jun 7, 2021
Management Tracks
New hires at Merck KGaA's neurology & immunology business; plus Repertoire, Kinnate, Allakos, Intercept and more
Amy Mahery, a 17-year veteran at Merck KGaA (Xetra:MRK), was named the pharma’s SVP and head of the neurology and immunology global business franchise; she was SVP and head of global market
BioCentury | Mar 27, 2020
Product Development
March 26 Quick Takes: Pear’s digital therapeutic approved for insomnia; plus Medimetriks-Otsuka, Merck KGaA, Jazz, Roche, EpiVax
BioCentury | Aug 23, 2019
Politics & Policy
Coalition forms to push changes in antimicrobial payment system
BioCentury | May 2, 2019
Company News
Forge, Basilea to develop antibiotics against unexploited targets
BioCentury | Jun 1, 2018
Emerging Company Profile
Scratching the surface
Oppilotech’s model finds new targets for Gram-negative antibiotic potentiators
BioCentury | Sep 21, 2017
Tools & Techniques
On your marks
How the slowly-progressing epigenetics field is moving away from cancer
BioCentury | Apr 29, 2017
Finance
Forging ahead
Forge's pursuit of metalloenzyme targets gains traction with $15M A round
BioCentury | Apr 28, 2017
Finance
1Q17 public-private partnership roundup
HIGHLIGHTS OF PUBLIC-PRIVATE PARTNERSHIPS FROM 1Q17
Items per page:
1 - 10 of 15